you are here: HomeNewsIndia

Zero COVID-19 cases reported in Mumbai's Dharavi for the first time

Dharavi had been adding around one to three COVID-19 cases daily since May 31. The cases of coronavirus infections being reported from the slum had peaked in April this year with 99 fresh cases being added on April 8.

June 14, 2021 / 07:10 PM IST
Representational image (Image: AP)

Representational image (Image: AP)

The Brihanmumbai Municipal Corporation (BMC) said that Mumbai's Dharavi, the biggest slum in Asia, reported zero COVID-19 cases for the first time on June 14. The coronavirus case tally in the slum area is 6,861 at present.

Dharavi had been adding around one to three COVID-19 cases daily since May 31. The cases of coronavirus infections being reported from the slum had peaked in April this year with 99 fresh cases being added on April 8.

However, the number of daily infections being added started declining gradually after COVID-19 restrictions were imposed in the city, with hardly a few cases being added in the past week.

Mumbai’s Dharavi was declared a COVID-19 hotspot during the first wave of the pandemic. On December 25, 2020, it had reported zero COVID-19 positive cases for the first time.

The last time the slum recorded zero new COVID-19 cases was on February 2, 2021, before the outbreak of the second wave of the coronavirus pandemic. The number of new coronavirus cases being reported daily started rising steadily thereafter with 70-90 COVID-19 cases being recorded every day during the peak between March and April.

Close

COVID-19 Vaccine

Frequently Asked Questions

View more
How does a vaccine work?

A vaccine works by mimicking a natural infection. A vaccine not only induces immune response to protect people from any future COVID-19 infection, but also helps quickly build herd immunity to put an end to the pandemic. Herd immunity occurs when a sufficient percentage of a population becomes immune to a disease, making the spread of disease from person to person unlikely. The good news is that SARS-CoV-2 virus has been fairly stable, which increases the viability of a vaccine.

How many types of vaccines are there?

There are broadly four types of vaccine — one, a vaccine based on the whole virus (this could be either inactivated, or an attenuated [weakened] virus vaccine); two, a non-replicating viral vector vaccine that uses a benign virus as vector that carries the antigen of SARS-CoV; three, nucleic-acid vaccines that have genetic material like DNA and RNA of antigens like spike protein given to a person, helping human cells decode genetic material and produce the vaccine; and four, protein subunit vaccine wherein the recombinant proteins of SARS-COV-2 along with an adjuvant (booster) is given as a vaccine.

What does it take to develop a vaccine of this kind?

Vaccine development is a long, complex process. Unlike drugs that are given to people with a diseased, vaccines are given to healthy people and also vulnerable sections such as children, pregnant women and the elderly. So rigorous tests are compulsory. History says that the fastest time it took to develop a vaccine is five years, but it usually takes double or sometimes triple that time.

View more
Show
Meanwhile, Mumbai’s COVID-19 tally rose by 700 cases on June 13 and increased to 7,16,579. The city also reported 19 COVID-19 deaths in the past 24 hours, pushed the toll to 15,183.
first published: Jun 14, 2021 05:32 pm

stay updated

Get Daily News on your Browser
Sections
ISO 27001 - BSI Assurance Mark